Skip to main content
. 2021 May 17;26(5):050901. doi: 10.1117/1.JBO.26.5.050901

Table 1.

Summary of tracer trials currently in phase 3 and beyond.

Presenter Tracer Tumor type
Costas Hadjipanayis, MD, PhD 5-ALA (Gleolan) Various neurosurgical applications
Janos L. Tanyi, MD, PhD FRa Ovarian cancer
Sunil Singhal, MD FRa Lung cancer
Alexander L. Vahrmeijer, MD CEA (SGM-101) Colon cancer
Barbara L. Smith, MD, PhD Protease-activated dye Breast cancer